2022
DOI: 10.1016/j.scr.2022.102766
|View full text |Cite
|
Sign up to set email alerts
|

Generation of ultra-treatment-resistant schizophrenia patient-derived induced pluripotent stem cell line UJSi002-A

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…OCT-4 is essential regulator of pluripotency in vivo and in vitro in embryonic stem cells. 30 Together with c-Myc, KFL4 and SOX2, OCT-4 mediates the reprogramming of somatic cells into induced-pluripotent stem cells in human and mouse. Interestingly, OCT-4 is also found to overexpress in CSCs.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…OCT-4 is essential regulator of pluripotency in vivo and in vitro in embryonic stem cells. 30 Together with c-Myc, KFL4 and SOX2, OCT-4 mediates the reprogramming of somatic cells into induced-pluripotent stem cells in human and mouse. Interestingly, OCT-4 is also found to overexpress in CSCs.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, stem cell transcription factors such as c‐Myc, OCT‐4 and Nanog are closely involved in stem cell development. OCT‐4 is essential regulator of pluripotency in vivo and in vitro in embryonic stem cells 30 . Together with c‐Myc, KFL4 and SOX2, OCT‐4 mediates the reprogramming of somatic cells into induced‐ pluripotent stem cells in human and mouse.…”
Section: Discussionmentioning
confidence: 99%